So we are all familiar with Hashan’s paper written about Neuren in Feb 2022 - A de-risked biotech with 4x upside when he was working for karst peak capital.https://www.livewiremarkets.com/wires/a-de-risked-biotech-with-4x-upside#
Well, he has backed it up, and has now written an updated paper as the founder of KP Rx. You can read it here
https://www.livewiremarkets.com/wires/neuren-where-to-from-here-2024-03-23
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$19.35 |
Change
0.080(0.42%) |
Mkt cap ! $2.443B | |||
| Open | High | Low | Value | Volume |
| $19.26 | $19.35 | $18.71 | $5.995M | 314.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 784 | $19.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.38 | 3085 | 1 |
View Market Depth
| Last trade - 16.10pm 15/09/2025 (20 minute delay) ? |
| NEU (ASX) Chart |